{"id":"W4413938704","doi":"10.1007/s40257-025-00975-3","title":"Efficacy and Safety of Upadacitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Phase 3 Randomized Clinical Trial Results Through 140 Weeks","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; University of Toronto; Probity Medical Research; SKiN Health; University of Calgary","funders":"AbbVie","keywords":"Medicine; Atopic dermatitis; Randomized controlled trial; Pharmacotherapy; Dermatology; Clinical trial; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.001964573,0.0002751206,0.004482116,0.0002802042,0.00005784374,0.00001186825,0.0002418604,0.0002707109,0.00002626988],"category_scores_gemma":[0.01270196,0.0001924986,0.0004830589,0.0004375162,0.002163574,0.0001491428,0.00008882943,0.0008957312,0.000005749836],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001921163,"about_ca_system_score_gemma":0.0007040698,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000145527,"about_ca_topic_score_gemma":0.000005793331,"domain_scores_codex":[0.9901041,0.003172542,0.005646069,0.0003960224,0.0003247434,0.0003564752],"domain_scores_gemma":[0.9855663,0.01120787,0.001992266,0.0003972926,0.000471171,0.0003650569],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8079889,0.002983728,0.161974,0.00005651638,0.0007450086,0.0003561162,0.0001339811,0.00001012832,1.03328e-7,0.0002340432,0.002742289,0.02277521],"study_design_scores_gemma":[0.75967,0.002932278,0.2329643,0.0005263958,0.0005886747,0.0003157398,0.0001032697,0.00008525136,0.00001002076,0.0004126037,0.002244492,0.0001470007],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9864163,0.0002871107,0.001466017,0.008886019,0.0005486723,0.001190798,0.00002828866,0.00001464792,0.001162093],"genre_scores_gemma":[0.9911082,0.0005303404,0.002754849,0.005437543,0.00008822948,0.00001331867,0.00002208857,0.00001615124,0.00002927253],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07099032,"threshold_uncertainty_score":0.9956145,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02776815026807483,"score_gpt":0.4017457693328107,"score_spread":0.3739776190647359,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}